{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009075","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.076463+00:00","generated_at":"2026-05-25T13:59:29.493165+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Hepion Pharmaceuticals provides unaudited balance sheet as of Jan 31, 2025; cash of $5.36M","bullets":["Cash and cash equivalents of $5.36M as of January 31, 2025.","Total assets of $6.5M, total liabilities of $0.55M.","Stockholders' equity of $5.95M, accumulated deficit of $238M.","No revenue or operational update provided; balance sheet only."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009075","json":"https://secwatch.observer/filing/0001493152-25-009075.json","markdown":"https://secwatch.observer/filing/0001493152-25-009075.md","text":"https://secwatch.observer/filing/0001493152-25-009075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/0001493152-25-009075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T13:59:29.493165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}